Share This Page
Drug Price Trends for NDC 33342-0299
✉ Email this page to a colleague
Average Pharmacy Cost for 33342-0299
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ESZOPICLONE 1 MG TABLET | 33342-0299-07 | 0.13331 | EACH | 2025-03-19 |
| ESZOPICLONE 1 MG TABLET | 33342-0299-07 | 0.12412 | EACH | 2025-02-19 |
| ESZOPICLONE 1 MG TABLET | 33342-0299-07 | 0.11946 | EACH | 2025-01-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 33342-0299
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| No data available in table | |||||||
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for the Drug NDC: 33342-0299
Understanding the National Drug Code (NDC)
To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number assigned to each drug product. It identifies the labeler, the product, and the trade package size. For NDC 33342-0299, the breakdown would be:
- Labeler Code: The first segment (33342) identifies the firm that manufactures, repackages, or relabels the drug.
- Product Code: The second segment (0299) identifies the specific strength, dosage form, and formulation of the drug.
- Package Code: The third segment identifies the package size and type[1][4].
Market Trends in the Pharmaceutical Industry
The pharmaceutical industry is undergoing significant changes driven by several key trends that will impact the market analysis and price projections for the drug NDC 33342-0299.
Digital Transformation and Innovation
The industry is expected to see substantial growth and transformation in 2025, driven by digital advancements and scientific innovations. This includes the integration of technologies like gen AI and increased use of data to boost operational efficiencies and drive breakthrough innovations. These advancements can lead to better production processes, potentially reducing costs and stabilizing or lowering prices[1].
Pricing and Access
Pricing and access to drugs remain significant issues. Nearly half of the C-suite executives surveyed expect these factors to significantly affect their strategies in 2025. This trend is particularly relevant when considering the pricing dynamics of specific drugs, as companies must balance profitability with patient access and affordability[1].
Generic Drugs and Biosimilars
Competition from generic drugs and biosimilars is a top trend, with 37% of respondents viewing it as a major concern. The patent cliff, with over $300 billion in sales at risk through 2030, is also a significant factor driving interest in mergers and acquisitions. If the drug NDC 33342-0299 is nearing the end of its patent life, the introduction of generics or biosimilars could significantly reduce its price[1].
Pricing Dynamics
Discounts and Programs
Programs like the 340B Drug Pricing Program play a crucial role in shaping the pricing landscape. This program requires drug companies to offer discounted prices on certain outpatient drugs to hospitals caring for large numbers of underserved patients. While these discounts are a small share of drug company revenues (approximately 3.1% of global revenues and 7% of U.S. revenues), they can impact the overall pricing strategy for drugs[1].
Market Pricing
The price of the drug NDC 33342-0299 would be influenced by various factors, including production costs, market demand, competition from generics or biosimilars, and regulatory policies. For instance, if the drug is nearing the end of its patent life, the price might decrease due to anticipated competition from generics[1].
Price Projections
Current Pricing
To project future prices, one must first understand the current pricing. This involves looking at recent pricing data, such as that provided in specialty MAC (Maximum Allowable Cost) lists or other pharmaceutical pricing databases. However, specific pricing data for NDC 33342-0299 may not be readily available in public sources, so industry reports and proprietary databases may be necessary[1][2].
Future Trends
Given the trends in the pharmaceutical industry:
- Digital Transformation: Increased efficiency and innovation could lead to better production processes, potentially reducing costs and stabilizing or lowering prices.
- Pricing and Access: Continued pressure on pricing and access could result in more competitive pricing strategies.
- Generic and Biosimilar Competition: If the drug is nearing the end of its patent life, the introduction of generics or biosimilars could significantly reduce its price[1].
Key Factors Influencing Price
Regulatory Changes
Changes in regulatory policies, such as those affecting the 340B program or patent exclusivity, can significantly impact drug pricing. For instance, expansions of the 340B program could lead to more discounted prices for certain patient groups[1].
Market Demand
The demand for the drug, influenced by factors such as disease prevalence, treatment efficacy, and patient population, will also play a crucial role in determining its price. If the drug treats a chronic condition with a growing patient population, demand is likely to increase, potentially stabilizing or increasing the price[4].
Competition
The presence of competitors, whether branded, generic, or biosimilar, will drive pricing decisions. As more drugs lose patent protection, the market is likely to see increased competition, which generally leads to lower prices. Analyzing the competitive landscape and comparing the pricing of similar drugs in the market helps in determining a competitive pricing strategy[1][4].
Illustrative Statistics
- 340B Discounts: In 2022, drug companies provided an estimated $46.5 billion in discounts to 340B hospitals, which is roughly 3.1% of global revenues and 7% of U.S. revenues[1].
- Patent Cliff: Over $300 billion in sales are at risk through 2030 due to expiring patents on high-revenue products, which could lead to significant price adjustments as generics and biosimilars enter the market[1].
Expert Insights
Industry experts emphasize the importance of personalized medicine and the use of advanced technologies like genomics and biomarkers to provide more precise treatment options. This not only improves efficacy but also reduces side effects, which can influence patient demand and, consequently, pricing strategies[1].
Forecasting Models
Regression Analysis
Using historical data, regression models can be built to predict future prices based on past trends and market conditions. This method helps in identifying the relationship between the drug's price and various market factors such as demand, competition, and economic conditions[4].
Time Series Analysis
Time series analysis involves identifying patterns and cycles in historical data to forecast future prices. This method can reveal seasonal patterns or other periodic changes in pricing that need to be considered in price projections[4].
External Factors
Economic Conditions
Economic conditions such as inflation rates and healthcare spending trends can significantly influence drug pricing. For example, if inflation is rising, drug prices may also increase to keep pace with the cost of living[4].
Policy Changes
Policy changes, such as changes in Medicare or Medicaid reimbursement rates, can impact the pricing of drugs. Staying updated with FDA regulations and other policy changes is essential for maintaining market position and compliance[4].
Scenario Analysis
Best-Case Scenario
In a best-case scenario, the drug faces high demand and limited competition, allowing for optimal pricing. This scenario assumes favorable market conditions and strong market positioning[4].
Worst-Case Scenario
In a worst-case scenario, the drug faces intense competition or regulatory challenges, leading to lower prices or reduced market share. This could happen if generics or biosimilars enter the market or if there are significant changes in regulatory policies[4].
Key Takeaways
- Market Trends: Digital transformation, pricing and access pressures, and competition from generics and biosimilars are key drivers.
- Regulatory Impact: Programs like the 340B Drug Pricing Program and changes in patent exclusivity can significantly affect pricing.
- Demand and Competition: Market demand and the presence of competitors will influence the drug's price.
- Technological Advancements: Innovations in genomics, biomarkers, and AI can improve treatment efficacy and reduce costs.
"Drug manufacturers may consider several factors when setting prices for brand-name prescription drugs, including a drug's patent status and the perceived value of a drug relative to its competitors, such as its ease of use; the unique characteristics of a drug, such as its novelty, the frequency of administration, and safety; the cost of therapeutically alternative drugs and alternative therapies, such as surgery, medical devices, and existing drugs; the disease treated; the size and characteristics of the patient market; research and development, manufacturing, and marketing costs; the willingness of customers to pay for the drug; and the amount of reimbursement for the drug from third-party payers."[3]
FAQs
Q: What is the National Drug Code (NDC) and how does it impact market analysis?
The National Drug Code (NDC) is a unique three-segment number that identifies the labeler, product, and package size of a drug. Understanding the NDC is crucial for analyzing the market and price projections of a specific drug.
Q: How does digital transformation affect drug pricing?
Digital transformation can lead to increased efficiency and innovation in drug production, potentially reducing costs and stabilizing or lowering prices.
Q: What role do generic drugs and biosimilars play in drug pricing?
Generic drugs and biosimilars significantly impact drug pricing by introducing competition, especially when branded drugs lose patent protection. This competition generally leads to lower prices.
Q: How do regulatory changes affect drug pricing?
Regulatory changes, such as those affecting the 340B program or patent exclusivity, can significantly impact drug pricing by altering the pricing landscape and affecting the availability of discounted prices.
Q: What is the importance of market demand in determining drug prices?
Market demand, influenced by factors such as disease prevalence, treatment efficacy, and patient population, plays a crucial role in determining the price of a drug. High demand with limited competition can lead to optimal pricing.
Sources
- DrugPatentWatch - Market Analysis and Price Projections for the Drug NDC: 33342-0309.
- Missouri Department of Social Services - MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023.
- Government Accountability Office - GAO-10-201 Brand-Name Prescription Drug Pricing.
- DrugPatentWatch - Latest drug prices and trends for NDC 33342-0308.
More… ↓
